Patent · US Active

Drug-delivery endovascular stent and method for treating restenosis

US8871292B2 · kind B2 · utility

3Cited by
99References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2012
Grant dateOct 28, 2014
Priority date
Expiry dateJul 24, 2032

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/416
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A radially expandable, endovascular stent designed for placement at a site of vascular injury, for inhibiting restenosis at the site, a method of using, and a method of making the stent. The stent includes a radially expandable body formed of one or more metallic filaments and a liquid-infusible mechanical anchoring layer attached to or formed in outer surface of the filaments. A drug coating in the stent is composed of a substantially polymer-free composition of an anti-restenosis drug, and has a substratum infused in the anchoring layer and a substantially continuous surface stratum of drug that is brought into direct contact with the vessel walls at the vascular site. Thus, the rate of release of the anti-restenosis drug from the surface stratum into said vascular site is determined solely by the composition of said drug coating.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.